Microfluidic genotyping by rapid serial PCR and high-speed melting analysis

Clinical Chemistry

Volumn 60, Issue 10, 2014, Pages 1306-1313

  Sundberg, Scott O ^a,b   Wittwer, Carl T ^a   Howell, Renée M ^c   Huuskonen, Jarkko ^c   Pryor, Robert J ^a   Farrar, Jared S ^a   Stiles, Heather M ^c   Palais, Robert A ^d   Knight, Ivor T ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Canon US Life Sciences   (United States)

^c Canon US Life Sci Inc   (United States)

^d UTAH VALLEY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AMPLICON; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RESOLUTION MELTING ANALYSIS; HOMOZYGOTE; HUMAN; MEASUREMENT ACCURACY; MELTING POINT; MICROFLUIDICS; NUCLEIC ACID ANALYSIS; RAPID SERIAL PCR ANALYSIS; TURNAROUND TIME; WORKFLOW; DEVICES; EQUIPMENT DESIGN; GENETICS; GENOTYPING TECHNIQUE; MICROFLUIDIC ANALYSIS; POLYMERASE CHAIN REACTION; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITION TEMPERATURE;

DNA; EQUIPMENT DESIGN; FACTOR V; GENOTYPE; GENOTYPING TECHNIQUES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICROFLUIDIC ANALYTICAL TECHNIQUES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSITION TEMPERATURE;

EID: 84921790459     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.223768     Document Type: Article

References (37)

1. Zhou L, Palais RA, Ye F, Chen J, Montgomery JL, Wittwer CT. Symmetric snapback primers for scanning and genotyping of the cystic fibrosis transmembrane conductance regulator gene. Clin Chem 2013;59:1052-61
2. Wittwer CT, Rasmussen RP, Ririe KM. Rapid PCR and melting analysis. In: Bustin SA, ed. The PCR revolution: basic technologies and applications. New York: Cambridge University Press 2010;48-69.
3. Zhang C, Xing D. Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends. Nucleic Acids Res 2007; 35:4223-37.
4. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by am-plicon melting analysis using LCGreen. Clin Chem 2003;49:853-60.
5. Reed GH, Wittwer CT. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 2004; 50:1748-54.
6. Vossen RH, Aten E, Roos A, den Dunnen JT. High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 2009;30:860-6.
7. Montgomery JL, Sanford LN, Wittwer CT. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn 2010;10:219-40.
8. Liew M, Pryor R, Palais R, Meadows C, Erali M, Lyon E, Wittwer C. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004;50: 1156-64.
9. Zhou L, Myers AN, Vandersteen JG, Wang L, Wittwer CT. Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem 2004;50:1328-35.
10. Zhou L, Errigo RJ, Lu H, Poritz MA, Seipp MT, Wittwer CT. Snapback primer genotyping with saturating DNA dye and melting analysis. Clin Chem 2008;54:1648-56.
11. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88: 3698-703.
12. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
13. Kluijtmans LA, Kastelein JJ, Lindemans J, Boers GH, Heil SG, Bruschke AV, et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997;96:2573-7.
14. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methyl-enetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72.
15. Seipp MT, Durtschi JD, Liew MA, Williams J, Damjanovich K, Pont-Kingdon G, et al. Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. J Mol Diagn 2007;9:284-9.
16. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D. Ultraconserved elements in the human genome. Science 2004; 304:1321-5.
17. Palais R, Wittwer CT. Mathematical algorithms for high-resolution DNA melting analysis. Methods Enzymol 2009;454:323-43.
18. Press W, Teukolsky S, Vetterling W, Flannery B. Salvitzky-Golay Smoothing filters numerical recipes: the art of scientific computing. New York: Cambridge University Press 2007;766-72.
19. Zhou L, Wang L, Palais R, Pryor R, Wittwer CT. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 2005;51:1770-7.
20. Coursey JS, Hasson KC. Compound calibrator for thermal sensors. US Patent Application 2012; 20120051390 A1.
21. Wittwer CT, Fillmore GC, Garling DJ. Minimizing the time required for DNA amplification by efficient heat transfer to small samples. Anal Biochem 1990;186:328-31.
22. Wittwer CT, Garling DJ. Rapid cycle DNA amplification: time and temperature optimization. Biotechniques 1991;10:76-83.
23. Wittwer CT, Hahn M, Kaul K. Rapid cycle realtime PCR-methods and applications: quantification. Berlin: Springer 2004.
24. Gundry CN, Vandersteen JG, Reed GH, Pryor RJ, Chen J, Wittwer CT. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. Clin Chem 2003;49:396-406.
25. Seipp MT, Pattison D, Durtschi JD, Jama M, Voelkerding KV, Wittwer CT. Quadruplex geno-typing of F5, F2, and MTHFR variants in a single closed tube by high-resolution amplicon melting. Clin Chem 2008;54:108-15.
26. Herrmann MG, Durtschi JD, Bromley LK, Wittwer CT, Voelkerding KV. Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes. Clin Chem 2006;52:494-503.
27. Herrmann MG, Durtschi JD, Wittwer CT, Voelk-erding KV. Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin Chem 2007;53: 1544-8.
28. O'Reilly R, Elphick HE. Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis. Drug Des Devel Ther 2013;7:929-37.
29. Andresen BS, Dobrowolski SF, O'Reilly L, Muen-zer J, McCandless SE, Frazier DM, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 2001;68:1408-18.
30. Roe CR DJ. Mitochondrial fatty acid oxidation disorders. In: Scriver CR SW, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B, eds. The metabolic bases of inherited disease. New York: McGraw-Hill 2001;2297-326.
31. Zhang L, Cui G, Li Z, Wang H, Ding H, Wang DW. Comparison of high-resolution melting analysis, TaqMan allelic discrimination assay, and Sanger sequencing for clopidogrel efficacy genotyping in routine molecular diagnostics. J Mol Diagn 2013; 15:600-6.
32. Pirmohamed M, Burnside G, Eriksson N, Jor-gensen AL, Toh CH, Nicholson T, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 2013;369:2294-303.
33. Evans JP, Berg JS, Olshan AF, Magnuson T, Rimer BK. We screen newborns, don't we? Realizing the promise of public health genomics. Genet Med 2013;15:332-4.
34. Dobrowolski SF, Ellingson C, Coyne T, Grey J, Martin R, Naylor EW, et al. Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyp-ing based upon thermal melt profiles. Mol Genet Metab 2007;91:218-27.
35. van der Stoep N, van Paridon CD, Janssens T, Krenkova P, Stambergova A, Macek M, et al. Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner. Hum Mutat 2009;30:899-909.
36. Guedes JG, Veiga I, Rocha P, Pinto P, Pinto C, Pinheiro M, et al. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer. BMC Cancer 2013;13:169.
37. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut 2011;60:116-29.